Synergistic therapeutic effect in gastric cancer cells produced by oncolytic adenovirus encoding Drosophila melanogaster deoxyribonucleoside kinase

Cancer Biology and Therapy

Volumn 11, Issue 10, 2011, Pages 874-882

  Zhu, Zhi ^a   Mao, Liang ^a   Zhao, Lei ^a   Sun, Zhe ^a   Wang, Zhenning ^a   Xu, Huimian ^a   Zheng, Xinyu ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Drosophila melanogaster multisubstrate deoxyribonucleoside kinase; Oncolytic adenovirus; Safe control; Suicide gene therapy; Virus therapy

Indexed keywords

5 (2 BROMOVINYL) 2' DEOXYURIDINE; DROSOPHILA MELANOGASTER DEOXYRIBONUCLEOSIDE KINASE; ONCOLYTIC ADENOVIRUS; UNCLASSIFIED DRUG;

ADENOVIRUS; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CELL KILLING; CONTROLLED STUDY; DRUG POTENCY; DRUG POTENTIATION; HUMAN; HUMAN CELL; IN VITRO STUDY; STOMACH CANCER; SUICIDE GENE THERAPY; VIRAL GENE DELIVERY SYSTEM; VIRUS REPLICATION;

ADENOVIRIDAE; ANIMALS; ARABINONUCLEOSIDES; CELL LINE; CELL SURVIVAL; DROSOPHILA MELANOGASTER; DRUG SYNERGISM; FEMALE; GENE ORDER; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HEK293 CELLS; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; ONCOLYTIC VIRUSES; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PRODRUGS; STOMACH NEOPLASMS; THYMIDINE; VIRUS REPLICATION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 79957446310     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.11.10.15182     Document Type: Article

References (33)

1. Zhang LH, Zhou XJ, Huang WB, Chen JY, Xie HL, Chen J, et al. The proteomics analysis of the gastric cancer and metastasis. Chin J Digest 2007; 21:78.
2. Roviello F, Pedrazzani C, Marrelli D, Neri A, Caruso S, Rampone B, et al. Surgical treatment of gastric cancer. Chir Ital 2008; 60:367-79.
3. Portsmouth D, Hlavaty J, Renner M. Suicide genes for cancer therapy. Mol Aspects Med 2007; 28:4-41.
4. Ilsley DD, Lee SH, Miller WH, Kuchta RD. Acyclic guanosine analogs inhibit DNA polymerases alpha, delta and epsilon with very different potencies and have unique mechanisms of action. Biochemistry (Mosc) 1995; 34:2504-10.
5. Fillat C, Carrió M, Cascante A, Sangro B. Suicide gene therapy mediated by the Herpes Simplex virus thymidine kinase gene/Ganciclovir system: fifteen years of application. Curr Gene Ther 2003; 3:13-26.
6. van Dillen IJ, Mulder NH, Vaalburg W, de Vries EF, Hospers GA. Influence of the bystander effect on HSV-tk/GCV gene therapy. Curr Gene Ther 2002; 2:307-22.
7. Agbaria R, Candotti F, Kelley JA, Hao Z, Johns DG, Cooney DA, et al. Biosynthetic ganciclovir triphosphate: its isolation and characterization from ganciclovir-treated herpes simplex thymidine kinase-transduced murine cells. Biochem Biophys Res Commun 2001; 289:525-30. (Pubitemid 33141086)
8. Hayashi K, Lee JB, Maitani Y, Toyooka N, Nemoto H, Hayashi T. The role of a HSV thymidine kinase stimulating substance, scopadulciol, in improving the efficacy of cancer gene therapy. J Gene Med 2006; 8:1056-67. (Pubitemid 44283002)
9. Zhu W, Burnette A, Dorjsuren D, Roberts PE, Huleihel M, Shoemaker RH, et al. Potent antiviral activity of north-methanocarbathymidine against Kaposi's sarcoma-associated herpesvirus. Antimicrob Agents Chemother 2005; 49:4965-73. (Pubitemid 41778907)
10. Boucher PD, Ostruszka LJ, Shewach DS. Synergistic enhancement of herpes simplex virus thymidine kinase/ganciclovir-mediated cytoxicity by hydroxyurea. Cancer Res 2000; 60:1631-6. (Pubitemid 30183435)
11. El-Aneed A. An overview of current delivery systems in cancer gene therapy. J Control Release 2004; 94:1-14. (Pubitemid 37542373)
12. Munch-Petersen B, Piskur J, Sondergaard L. Four deoxynucleoside kinase activities from Drosophila melanogaster are contained within a single monomeric enzyme, a new multifunctional deoxynucleoside kinase. J Biol Chem 1998; 273:3926-31.
13. Zheng X, Johansson M, Karlsson A. Retroviral transduction of cancer cell lines with the gene encoding Drosophila melanogaster multisubstrate deoxyribonucleoside kinase. J Biol Chem 2000; 275:39125-9.
14. Chen L, Chen D, Gong M, Na M, Li L, Wu H, et al. Concomitant use of Ad5/35 chimeric oncolytic adeno-virus with TRAIL gene and taxol produces synergistic cytotoxicity in gastric cancer cells. Cancer Lett 2009; 284:141-8.
15. Zhang ZL, Zou WG, Luo CX, Li BH, Wang JH, Sun LY, et al. An armed oncolytic adenovirus system, ZD55-gene, demonstrating potent antitumoral efficacy. Cell research 2003; 13:481-9. (Pubitemid 43231842)
16. Zheng X, Johansson M, Karlsson A. Nucleoside analog cytotoxicity and bystander cell killing of cancer cells expressing Drosophila melanogaster deoxyribonucleoside kinase in the nucleus or cytosol. Biochem Biophys Res Commun 2001; 289:229-33.
17. Wang L, Eriksson S. 5-Bromovinyl 2′-deoxyuridine phosphorylation by mitochondrial and cytosolic thymidine kinase (TK2 and TK1) and its use in selective measurement of TK2 activity in crude extracts. Nucleosides Nucleotides Nucleic Acids 2008; 27:858-62. (Pubitemid 351948586)
18. Cappellacci L, Franchetti P, Vita P, Petrelli R, Grifantini M. Synthesis and antitumor activity of a heterodinucleotide of BVDU and gemcitabine. Nucleosides Nucleotides Nucleic Acids 2008; 27:460-8. (Pubitemid 351878531)
19. De Clercq E. Antiviral drug discovery and development: Where chemistry meets with biomedicine. Antiviral Res 2005; 67:56-75. (Pubitemid 41112622)
20. Thumbi DK, Arif BM, Krell PJ. Susceptibility of Autographa californica multiple nucleopolyhedrovirus to inhibitors of DNA replication. J Virol Methods 2007; 146:209-17. (Pubitemid 350026636)
21. Odoux C, Albers A. Additive effects of TRAIL and paclitaxel on cancer cells: implications for advances in cancer therapy. Vitam Horm 2004; 67:385-407. (Pubitemid 39753922)
22. Wildner O, Blaese RM, Morris JC. Therapy of colon cancer with oncolytic adenovirus is enhanced by the addition of herpes simplex virus-thymidine kinase. Cancer Res 1999; 59:410-13. (Pubitemid 29048876)
23. Wildner O, Morris JC, Vahanian NN, Ford H Jr, Ramsey WJ, Blaese RM. Adenoviral vectors capable of replication improve the efficacy of HSVtk/GCV suicide gene therapy of cancer. Gene Ther 1999; 6:57-62. (Pubitemid 29043694)
24. Wildner O, Morris JC. Therapy of peritoneal carcinomatosis from colon cancer with oncolytic adenoviruses. J Gene Med 2000; 2:353-60.
25. Lambright ES, Amin K, Wiewrodt R, Force SD, Lanuti M, Propert KJ, et al. Inclusion of the herpes simplex thymidine kinase gene in a replicating adenovirus does not augment antitumor efficacy. Gene Ther 2001; 8:946-53. (Pubitemid 32600151)
26. Raki M, Hakkarainen T, Bauerschmitz GJ, Särkioja M, Desmond RA, Kanerva A, et al. Utility of TK/GCV in the context of highly effective oncolysis mediated by a serotype 3 receptor targeted oncolytic adenovirus. Gene Ther 2007; 14:1380-8. (Pubitemid 47423737)
27. Wildner O, Morris JC. The role of the E1B 55 kDa gene product in oncolytic adenoviral vectors expressing herpes simplex virus-tk: assessment of antitumor efficacy and toxicity. Cancer Res 2000; 60:4167-74. (Pubitemid 30636600)
28. Romano G, Michell P, Pacilio C, Giordano A. Latest developments in gene transfer technology: achievements, perspectives and controversies over therapeutic applications. Stem Cells 2000; 18:19-39. (Pubitemid 30064889)
29. Cramer SD, Sun J, Zheng SL, Xu J, Peehl DM. Association of prostate-specific antigen promoter geno-type with clinical and histopathologic features of prostate cancer. Cancer Epidemiol Biomarkers Prev 2008; 17:2451-7.
30. Zhang G, Liu T, Chen YH, Chen Y, Xu M, Peng J, et al. Tissue specific cytotoxicity of colon cancer cells mediated by nanoparticle-delivered suicide gene in vitro and in vivo. Clin Cancer Res 2009; 15:201-7.
31. Fujiwara T, Tanaka N. Telomerase-specific oncolytic virotherapy for human cancer with the hTERT promoter. Uirusu 2008; 58:11-8.
32. Arner ESJ, Spasokoukotskaja T, Eriksson S. Selective assays for thymidine kinase 1 and 2 and deoxycytidine kinase and their activities in extracts from human cells and tissues. Biochem Biophys Res Commun 1992; 188:712-8.
33. Usuba O, Schulman JL, Deatly AM, Bona CA, Moran TM. New method for titration of virus infectivity by immunostaining. Viral Immunol 1990; 3:237-41. (Pubitemid 20342168)